Gene-Disorder Association · Article
Gene
KRASKRAS Proto-Oncogene, GTPase
×
First reported
1997
Supporting publications
23
Manually curatedApproved treatment annotated
Association Review
In brief
The association between KRAS (KRAS Proto-Oncogene, GTPase) and Endometrial Cancer is reported, with clinical genetic testing available.
Sources
1
Clinical variants
2
Symptoms
2
Compounds
2
Trials
141of 5,175 via KRAS compounds
Publications
23
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Endometrial Cancer
The disorder
20 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features
1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
ClinVar and variant evidence
Genetic basis
2 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
07
Mechanism overlap
Shared mechanisms
1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
08
Interventions
Therapeutics
2 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
09
Human studies
Clinical trials
5,175 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
23 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
11
Provenance
References & sources
19 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access